Odyssey Health (ODYY) Cash from Operations Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 20.35% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -48.14% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.50% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 50.11% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -14.75% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.83% |
| 10 | Odyssey Health | - | - | - | 32.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 32.00% |
| Oct 31, 2025 | 0.08% |
| Jul 31, 2025 | -26.92% |
| Apr 30, 2025 | 83.96% |
| Jan 31, 2025 | 51.91% |
| Oct 31, 2024 | 40.25% |
| Jul 31, 2024 | 55.34% |
| Apr 30, 2024 | 53.63% |
| Jan 31, 2024 | -42.91% |
| Oct 31, 2023 | 41.78% |
| Jul 31, 2023 | 27.05% |
| Apr 30, 2023 | -85.33% |
| Jan 31, 2023 | -108.61% |
| Oct 31, 2022 | -9.85% |
| Jul 31, 2022 | 176.07% |
| Apr 30, 2022 | -220.91% |
| Jan 31, 2022 | -937.23% |
| Oct 31, 2021 | -298.70% |
| Jul 31, 2021 | -142.63% |
| Apr 30, 2021 | -750.68% |
| Jan 31, 2021 | -71.74% |
| Oct 31, 2020 | -112.43% |
| Jul 31, 2020 | -102.68% |
| Apr 30, 2020 | 35.04% |
| Jan 31, 2020 | -97.91% |
| Oct 31, 2019 | -415.15% |
| Jul 31, 2019 | -81.81% |
| Apr 30, 2019 | -12.48% |
| Jan 31, 2019 | 67.78% |
| Oct 31, 2018 | 2.04% |
| Jul 31, 2018 | -278.17% |
| Apr 30, 2018 | -37.91% |
| Jan 31, 2018 | -44.43% |
| Oct 31, 2017 | -31.25% |